Alia S Dadabhai

Medicine & Life Sciences

1. Liver Cirrhosis 100%
2. Vitamin D 80%
3. Rabeprazole 65%
4. Meta-Analysis 64%
5. Fibrosis 64%
6. Hepacivirus 64%
7. Systematic Reviews 63%
8. Chronic Hepatitis C 62%
9. End Stage Liver Disease 61%
10. Alcoholic Hepatitis 59%
11. Transjugular Intrahepatic Portasystemic Shunt 59%
12. Elasticity Imaging Techniques 52%
13. Vibration 47%
14. Non-alcoholic Fatty Liver Disease 46%
15. Constipation 44%
16. African Continental Ancestry Group 42%
17. Liver 39%
18. Case-Control Studies 34%
19. Comorbidity 33%
20. Acids 32%
21. Liver Diseases 29%
22. Clinical Trials 28%
23. Quality of Life 27%
24. Mortality 26%
25. Pentoxifylline 22%
26. Gastroesophageal Reflux 22%
27. Serum 20%
28. Proton Pump Inhibitors 18%
29. Liver Transplantation 17%
30. Placebos 17%
31. Population 16%
32. Veterans 16%
33. factor X receptors 15%
34. Research Personnel 15%
35. Biopsy 14%
36. Middle Aged 14%
37. Early Detection of Cancer 13%
38. Colonic Neoplasms 13%
39. Alcohols 12%
40. Steroids 12%
41. PubMed 12%
42. Virus Diseases 11%
43. Alcoholic Liver Cirrhosis 11%
44. HIV-2 11%
45. Alcoholic Liver Diseases 10%
46. Therapeutics 10%
47. Hepatic Encephalopathy 10%
48. Induced Pluripotent Stem Cells 9%
49. Demography 9%
50. Fatty Liver 9%